Carlyle walks away from Chemring takeover
US asset management firm, The Carlyle Group, has called off its long, drawn-out discussions with Chemring about a potential takeover of the FTSE 250 defence contractor.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Twice daily
MoneyWeek
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Four times a week
Look After My Bills
Sign up to our free money-saving newsletter, filled with the latest news and expert advice to help you find the best tips and deals for managing your bills. Start saving today!
US asset management firm, The Carlyle Group, has called off its long, drawn-out discussions with Chemring about a potential takeover of the FTSE 250 defence contractor.
Ahead of the US firm's third-quarter results scheduled for release on Thursday morning in New York, the company announced that it no longer intends to make an offer for Chemring.
In a statement on Wednesday afternoon, Chemring said: "On August 17th 2012, Chemring announced that it had received a highly preliminary expression of interest from Carlyle in relation to a possible offer. Carlyle today confirms that it does not intend to make an offer for Chemring."
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Shares were down over 13%at 234.5p by the close in London.
The offer deadline had been pushed back on two separate occasions; the company said it would give a further update in its pre-close trading update on November 27th.
Chemring disappointed the market last week after reducing its profit expectations for the year ended October 31st following delays and technical problems in a number of contracts.
The company attempted to reassure investors that near-term opportunities remain intact despite the withdrawal of interest and tough market conditions.
"Whilst Chemring continues to face near term challenges resulting from defence budget constraints in its NATO markets, which are not expected to ease in the immediate future, the company has market leading positions and manufacturing expertise in the fields of counter-IED, countermeasures, munitions and pyrotechnics.
"In addition, the company's non-NATO markets will continue to provide the business with further opportunities and gives a balanced exposure to global defence spending."
-
What is a care fees annuity and how much does it cost?How we will be cared for in our later years – and how much we are willing to pay for it – are conversations best had as early as possible. One option to cover the cost is a care fees annuity. We look at the pros and cons.
-
How to navigate the inheritance tax paperwork maze in nine clear stepsFamilies who cope best with inheritance tax (IHT) paperwork are those who plan ahead, say experts. We look at all documents you need to gather, regardless of whether you have an IHT bill to pay.
